​
​

GeneDx (WGS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

GeneDx Revenue Highlights

Latest Revenue (Y)

$202.57M

Latest Revenue (Q)

$76.87M

Main Segment (Y)

Diagnostic Test

GeneDx Revenue by Period

GeneDx Revenue by Year

DateRevenueChange
2023-12-31$202.57M-13.69%
2022-12-31$234.69M10.60%
2021-12-31$212.19M18.33%
2020-12-31$179.32M-8.59%
2019-12-31$196.17M-

GeneDx generated $202.57M in revenue during NA 2023, up -13.69% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

GeneDx Revenue by Quarter

DateRevenueChange
2024-09-30$76.87M9.02%
2024-06-30$70.51M12.96%
2024-03-31$62.42M8.72%
2023-12-31$57.42M7.72%
2023-09-30$53.30M9.44%
2023-06-30$48.71M12.90%
2023-03-31$43.14M-29.68%
2022-12-31$61.35M-26.29%
2022-09-30$83.23M130.13%
2022-06-30$36.17M-32.95%
2022-03-31$53.94M-6.68%
2021-12-31$57.80M33.87%
2021-09-30$43.18M-7.87%
2021-06-30$46.87M-27.00%
2021-03-31$64.20M0.38%
2020-12-31$63.96M65.66%
2020-09-30$38.61M-

GeneDx generated $76.87M in revenue during Q3 2024, up 9.02% compared to the previous quarter, and up 157.83% compared to the same period a year ago.

GeneDx Revenue Breakdown

GeneDx Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
Product and Service, Other$7.36M
Diagnostic Test$227.33M

GeneDx's latest annual revenue breakdown by segment (product or service), as of Dec 22: Diagnostic Test (96.86%), and Product and Service, Other (3.14%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24
Diagnostic Test, Institutional Customers$17.41M$16.70M
Diagnostic Test, Self Pay$460.00K$692.00K
Diagnostic Test, Third Party Insurance$59.54M$52.05M
Product and Service, Other$-544.00K$1.07M
Diagnostic Test$77.42M$69.44M

GeneDx's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Diagnostic Test (50.18%), Diagnostic Test, Third Party Insurance (38.59%), Diagnostic Test, Institutional Customers (11.29%), Diagnostic Test, Self Pay (0.30%), and Product and Service, Other (-0.35%).

GeneDx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PRVAPrivia Health Group$1.66B$422.33M
BBLNBabylon$1.11B$311.12M
CERTCertara$354.34M$94.82M
CPSITruBridge$326.65M$82.71M
HSTMHealthStream$279.06M$73.09M
DHDefinitive Healthcare$251.41M$62.70M
WGSGeneDx$202.57M$76.87M
NRCNational Research$148.58M$35.82M
ETAOETAO$58.06M-
HCTIHealthcare Triangle$33.20M$2.41M
EUDAEUDA Health$3.71M$1.11M
AKLIAkili$1.68M$383.00K
ACONAclarion$75.40K$10.97K

WGS Revenue FAQ

What is GeneDx’s yearly revenue?

GeneDx's yearly revenue for 2023 was $202.57M, representing a decrease of -13.69% compared to 2022. The company's yearly revenue for 2022 was $234.69M, representing an increase of 10.60% compared to 2021. WGS's yearly revenue for 2021 was $212.2M, representing an increase of 18.33% compared to 2020.

What is GeneDx’s quarterly revenue?

GeneDx's quarterly revenue for Q3 2024 was $76.87M, a 9.02% increase from the previous quarter (Q2 2024), and a 44.22% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $70.51M, a 12.96% increase from the previous quarter (Q1 2024), and a 44.77% increase year-over-year (Q2 2023). WGS's quarterly revenue for Q1 2024 was $62.42M, a 8.72% increase from the previous quarter (Q4 2023), and a 44.70% increase year-over-year (Q1 2023).

What is GeneDx’s revenue growth rate?

GeneDx's revenue growth rate for the last 3 years (2021-2023) was -4.54%, and for the last 5 years (2019-2023) was 3.26%.

What are GeneDx’s revenue streams?

GeneDx's revenue streams in c 22 are Product and Service, Other, and Diagnostic Test. Product and Service, Other generated $7.36M in revenue, accounting 3.14% of the company's total revenue Diagnostic Test generated $227.33M in revenue, accounting 96.86% of the company's total revenue

What is GeneDx’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of GeneDx was Diagnostic Test. This segment made a revenue of $227.33M, representing 96.86% of the company's total revenue.